BRPI1010748A2 - comprimidos de ibuprofeno sódico e métodos para produzir composições farmacêuticas incluindo ibupofreno sódico. - Google Patents
comprimidos de ibuprofeno sódico e métodos para produzir composições farmacêuticas incluindo ibupofreno sódico.Info
- Publication number
- BRPI1010748A2 BRPI1010748A2 BRPI1010748A BRPI1010748A BRPI1010748A2 BR PI1010748 A2 BRPI1010748 A2 BR PI1010748A2 BR PI1010748 A BRPI1010748 A BR PI1010748A BR PI1010748 A BRPI1010748 A BR PI1010748A BR PI1010748 A2 BRPI1010748 A2 BR PI1010748A2
- Authority
- BR
- Brazil
- Prior art keywords
- sodium
- ibupofrene
- methods
- pharmaceutical compositions
- compositions including
- Prior art date
Links
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 title 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title 1
- 229960001680 ibuprofen Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229910052708 sodium Inorganic materials 0.000 title 1
- 239000011734 sodium Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21914909P | 2009-06-22 | 2009-06-22 | |
PCT/US2010/039346 WO2011005478A2 (en) | 2009-06-22 | 2010-06-21 | Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1010748A2 true BRPI1010748A2 (pt) | 2016-03-22 |
Family
ID=42543076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1010748A BRPI1010748A2 (pt) | 2009-06-22 | 2010-06-21 | comprimidos de ibuprofeno sódico e métodos para produzir composições farmacêuticas incluindo ibupofreno sódico. |
Country Status (23)
Country | Link |
---|---|
US (4) | US20100323005A1 (pt) |
EP (1) | EP2445486B1 (pt) |
JP (2) | JP2012530781A (pt) |
KR (2) | KR101429331B1 (pt) |
CN (2) | CN102802613A (pt) |
AR (1) | AR077189A1 (pt) |
AU (1) | AU2010270976B2 (pt) |
BR (1) | BRPI1010748A2 (pt) |
CA (1) | CA2764740C (pt) |
CO (1) | CO6480926A2 (pt) |
ES (1) | ES2654331T3 (pt) |
HK (1) | HK1213783A1 (pt) |
HU (1) | HUE037827T2 (pt) |
IL (2) | IL216602B (pt) |
MX (2) | MX347467B (pt) |
NZ (2) | NZ620828A (pt) |
PL (1) | PL2445486T3 (pt) |
PT (1) | PT2445486T (pt) |
RU (3) | RU2011150661A (pt) |
SG (2) | SG10201509312UA (pt) |
TW (3) | TWI504393B (pt) |
WO (1) | WO2011005478A2 (pt) |
ZA (1) | ZA201109501B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2965746B1 (en) | 2014-07-10 | 2019-03-13 | Santa Farma Ilaç Sanayi A.S. | An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate |
IL256299B2 (en) * | 2015-06-30 | 2023-11-01 | Genentech Inc | Immediate-release tablets containing a drug and processes for creating the tablets |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4476248A (en) * | 1983-02-28 | 1984-10-09 | The Upjohn Company | Crystallization of ibuprofen |
US4609675A (en) * | 1984-08-17 | 1986-09-02 | The Upjohn Company | Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing |
IT1197038B (it) * | 1986-08-01 | 1988-11-25 | Zambon Spa | Composizione farmaceutica ad attivita' analgesica |
US4980375A (en) * | 1987-07-10 | 1990-12-25 | Sterling Drug Inc. | Onset-hastened/enhanced antipyretic response |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
US5104648A (en) * | 1989-02-02 | 1992-04-14 | Mallinckrodt Specialty Chemicals Company | High ibuprofen content granulations |
US5262179A (en) * | 1989-09-13 | 1993-11-16 | Nicholas Kiwi Pty Ltd. | Non-effervescent ibuprofen compositions |
US5075114A (en) * | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
CA2061520C (en) * | 1991-03-27 | 2003-04-22 | Lawrence J. Daher | Delivery system for enhanced onset and increased potency |
DE69231359T2 (de) * | 1991-05-13 | 2001-02-08 | The Boots Co., Plc | Ibuprofen-salz enthaltende pharmazeutische zusammensetzung |
ATE180668T1 (de) * | 1992-12-01 | 1999-06-15 | Spirig Ag | S(+)-ibuprofen enthaltende arzneimittel |
GB9603699D0 (en) * | 1996-02-21 | 1996-04-17 | Boots Co Plc | Therapeutic composition |
WO1999008670A1 (en) * | 1997-08-20 | 1999-02-25 | Guglietta, Antonio | Gaba analogs to prevent and treat gastrointestinal damage |
JP2002510336A (ja) * | 1998-04-11 | 2002-04-02 | エレカッパ・ユウロテラピッチ・ソシエタ・ペル・アチオニ | 水溶性ケトプロフェン塩を含有する薬学的調製物及びその使用方法 |
CH693586A8 (de) * | 2002-10-14 | 2003-12-15 | Roche Consumer Health Ag | Darreichungsform von Ibuprofen-Natrium. |
US20080020042A1 (en) * | 2003-10-14 | 2008-01-24 | Peter Gruber | Dosage form of sodium ibuprofen |
WO2005121061A1 (en) * | 2004-06-07 | 2005-12-22 | Strides Research And Specialty Chemicals Limited | Novel process for producing ibuprofen sodium dihydrate |
JP2008509207A (ja) * | 2004-08-12 | 2008-03-27 | レキット ベンキーザー ヘルスケア (ユーケイ) リミテッド | 溶融押出しにより作製するパラセタモール、nsaid及び糖アルコールを含む顆粒 |
EP2043613A1 (en) * | 2006-07-14 | 2009-04-08 | Fmc Corporation | Solid form |
FI20080348A0 (fi) * | 2008-02-15 | 2008-05-09 | Atacama Labs Oy | Uudenlainen farmaseuttinen formulaatio |
-
2010
- 2010-06-21 AU AU2010270976A patent/AU2010270976B2/en active Active
- 2010-06-21 ES ES10725949.1T patent/ES2654331T3/es active Active
- 2010-06-21 NZ NZ620828A patent/NZ620828A/en unknown
- 2010-06-21 RU RU2011150661/15A patent/RU2011150661A/ru not_active Application Discontinuation
- 2010-06-21 TW TW102102717A patent/TWI504393B/zh active
- 2010-06-21 SG SG10201509312UA patent/SG10201509312UA/en unknown
- 2010-06-21 CN CN2010800278197A patent/CN102802613A/zh active Pending
- 2010-06-21 NZ NZ628603A patent/NZ628603A/en unknown
- 2010-06-21 CN CN201510264299.6A patent/CN104922084B/zh active Active
- 2010-06-21 KR KR1020117030572A patent/KR101429331B1/ko active IP Right Grant
- 2010-06-21 JP JP2012517628A patent/JP2012530781A/ja active Pending
- 2010-06-21 MX MX2015011691A patent/MX347467B/es unknown
- 2010-06-21 HU HUE10725949A patent/HUE037827T2/hu unknown
- 2010-06-21 TW TW099120137A patent/TWI477270B/zh active
- 2010-06-21 WO PCT/US2010/039346 patent/WO2011005478A2/en active Application Filing
- 2010-06-21 SG SG2011086865A patent/SG176221A1/en unknown
- 2010-06-21 RU RU2015122313A patent/RU2715680C2/ru active
- 2010-06-21 US US12/819,760 patent/US20100323005A1/en not_active Abandoned
- 2010-06-21 PT PT107259491T patent/PT2445486T/pt unknown
- 2010-06-21 PL PL10725949T patent/PL2445486T3/pl unknown
- 2010-06-21 MX MX2011013912A patent/MX2011013912A/es active IP Right Grant
- 2010-06-21 CA CA2764740A patent/CA2764740C/en active Active
- 2010-06-21 EP EP10725949.1A patent/EP2445486B1/en active Active
- 2010-06-21 TW TW103138225A patent/TWI542344B/zh active
- 2010-06-21 KR KR1020147009816A patent/KR20140053414A/ko not_active Application Discontinuation
- 2010-06-21 BR BRPI1010748A patent/BRPI1010748A2/pt not_active Application Discontinuation
- 2010-06-22 AR ARP100102196A patent/AR077189A1/es unknown
-
2011
- 2011-11-24 IL IL216602A patent/IL216602B/en active IP Right Grant
- 2011-12-22 ZA ZA2011/09501A patent/ZA201109501B/en unknown
- 2011-12-22 CO CO11177193A patent/CO6480926A2/es not_active Application Discontinuation
-
2013
- 2013-05-20 HK HK16101788.6A patent/HK1213783A1/zh unknown
-
2015
- 2015-04-24 US US14/695,470 patent/US20150231099A1/en not_active Abandoned
-
2016
- 2016-07-25 JP JP2016145476A patent/JP6446413B2/ja active Active
-
2017
- 2017-04-20 US US15/492,680 patent/US20170319518A1/en not_active Abandoned
- 2017-08-14 IL IL253975A patent/IL253975A0/en unknown
-
2019
- 2019-07-24 US US16/521,128 patent/US20200009093A1/en not_active Abandoned
- 2019-12-09 RU RU2019140368A patent/RU2019140368A/ru unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2020003I1 (lt) | Dvisluoksnės tabletės formuluotės | |
SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
DK2395834T3 (da) | Natriumnitrit-holdige farmaceutiske sammensætninger | |
BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
BRPI1004940A2 (pt) | composição farmacêutica | |
BR112012011733A2 (pt) | formulações de comprimido de liberação imediata | |
BRPI0919466A2 (pt) | composição farmacêutica para liberação modificada | |
BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
DK3061445T3 (da) | Højkoncentrerede farmaceutiske formuleringer | |
BR112012011902A2 (pt) | cápsula farmacêutica | |
SMT201400069B (it) | Formulazione farmaceutica | |
BR112012012108A2 (pt) | composição farmacêutica compreendendo propofol | |
BRPI1012875A2 (pt) | composições farmacêuticas sólidas e processos para sua produção | |
BRPI1015939A2 (pt) | composição farmacêutica | |
BRPI1012539A2 (pt) | composições farmacêuticas | |
BRPI1016190A2 (pt) | compostos farmacêuticos. | |
BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
IT1394400B1 (it) | Composizioni farmaceutiche | |
BRPI1011412A2 (pt) | composição para liberação sustentada de droga compreendendo alutinante geopolimérico | |
BRPI1007484A2 (pt) | composição farmacêutica para administração oral | |
BRPI0922653A2 (pt) | preparação farmacêutica | |
BR112012003149A2 (pt) | composição farmacêutica | |
BR112012001340A2 (pt) | composições farmacêuticas | |
BRPI0918539A2 (pt) | preparação farmacêutica sólida para administração oral | |
BRPI1006076A2 (pt) | composicoes farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B25G | Requested change of headquarter approved |
Owner name: WYETH LLC (US) |
|
B25A | Requested transfer of rights approved |
Owner name: PF CONSUMER HEALTHCARE 1 LLC (US) |